Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of California, San Diego, San Diego, California St.Jude Clinical Research, Doral, Florida AP Medical Research, Miami, Florida Altoona Center for Research, Duncansville, Pennsylvania Prolato Clinical Research Center, Houston, Texas